SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-015756
Filing Date
2022-08-09
Accepted
2022-08-09 07:30:57
Documents
14
Period of Report
2022-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qtnt-20220809.htm   iXBRL 8-K 49628
2 EX-99.1 qtnt-ex99_1.htm EX-99.1 531182
3 GRAPHIC img95527580_0.jpg GRAPHIC 3380
  Complete submission text file 0000950170-22-015756.txt   733901

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qtnt-20220809_pre.xml EX-101.PRE 11455
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qtnt-20220809.xsd EX-101.SCH 2480
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qtnt-20220809_lab.xml EX-101.LAB 17299
8 EXTRACTED XBRL INSTANCE DOCUMENT qtnt-20220809_htm.xml XML 4695
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 221146409
SIC: 2835 In Vitro & In Vivo Diagnostic Substances